NCT02657486View on ClinicalTrials.gov

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

NAActive, not recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Bladder CancerNon-Muscle-Invasive Urothelial Carcinoma
Interventions
DRUG

BGJ398

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02657486 - BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder | Biotech Hunter | Biotech Hunter